Intersect ENT (XENT) Misses Q2 EPS by 6c

Intersect ENT (NASDAQ: XENT) reported Q2 EPS of ($0.49), $0.06 worse than the analyst estimate of ($0.43). Revenue for the quarter came in at $27.3 million versus the consensus estimate of $28.02 million.

For earnings history and earnings-related data on Intersect ENT (XENT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c